Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sukhmani K Padda

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Treatment Options in Oncology|June 29, 2018
Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision MedicineJacqueline V Aredo, Sukhmani K Padda
Cancer Treatment and Research Communications|February 3, 2020
Latest advances in management of small cell lung cancer and other neuroendocrine tumors of the lungHussein A Assi, Sukhmani K Padda
Current Oncology Reports|March 19, 2022
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?Thomas Yang Sun, Andrew Hendifar, Sukhmani K Padda
Mediastinum (Hong Kong, China)|February 4, 2022
The role of induction therapy for thymic malignancies: a narrative reviewDeven C Patel, Joseph B Shrager, Sukhmani K Padda
Advances in Therapy|September 26, 2021
Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable DiscussionMillie Das, Sukhmani K Padda, Jared Weiss, et al.
Seminars in Oncology|February 26, 2014
Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapySukhmani K Padda, Bryan M Burt, Nicholas Trakul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020
Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLCJessica A Hellyer, Sukhmani K Padda, Maximilian Diehn, et al.
Cancer Treatment and Research Communications|December 17, 2021
Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung CancerJacqueline V Aredo, Heather A Wakelee, Joel W Neal, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2020
Everolimus in the treatment of metastatic thymic epithelial tumorsJessica A Hellyer, Madhu M Ouseph, Sukhmani K Padda, et al.
JTO Clinical and Research Reports|May 23, 2022
Autoimmune Disease in Patients With Advanced Thymic Epithelial TumorsSurbhi Singhal, Jessica Hellyer, Madhu M Ouseph, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Treatment Options in Oncology|June 29, 2018
Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision MedicineJacqueline V Aredo, Sukhmani K Padda
Cancer Treatment and Research Communications|February 3, 2020
Latest advances in management of small cell lung cancer and other neuroendocrine tumors of the lungHussein A Assi, Sukhmani K Padda
Current Oncology Reports|March 19, 2022
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?Thomas Yang Sun, Andrew Hendifar, Sukhmani K Padda
Mediastinum (Hong Kong, China)|February 4, 2022
The role of induction therapy for thymic malignancies: a narrative reviewDeven C Patel, Joseph B Shrager, Sukhmani K Padda
Advances in Therapy|September 26, 2021
Advances in Treatment of Recurrent Small Cell Lung Cancer (SCLC): Insights for Optimizing Patient Outcomes from an Expert Roundtable DiscussionMillie Das, Sukhmani K Padda, Jared Weiss, et al.
Seminars in Oncology|February 26, 2014
Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapySukhmani K Padda, Bryan M Burt, Nicholas Trakul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2020
Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLCJessica A Hellyer, Sukhmani K Padda, Maximilian Diehn, et al.
Cancer Treatment and Research Communications|December 17, 2021
Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung CancerJacqueline V Aredo, Heather A Wakelee, Joel W Neal, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2020
Everolimus in the treatment of metastatic thymic epithelial tumorsJessica A Hellyer, Madhu M Ouseph, Sukhmani K Padda, et al.
JTO Clinical and Research Reports|May 23, 2022
Autoimmune Disease in Patients With Advanced Thymic Epithelial TumorsSurbhi Singhal, Jessica Hellyer, Madhu M Ouseph, et al.
Pageof 7